Jan. 22 at 9:00 PM
$ELTP Because ELTP is a micro‑cap specialty pharma with revenue, approved products, and a pipeline, the most likely offer would be based on:
A premium to the current share price
Value of existing revenue streams
Value of pipeline assets (especially abuse‑deterrent opioids)
Strategic value to the acquiring company
For companies like ELTP (sub‑
$200M market cap), the standard takeover premium is:
50%–100% for companies with modest revenue
100%–200% for companies with strategic assets
Bottom Line
A realistic acquisition offer for ELTP would most likely fall in the range of:
2×–4× the current share price